Clinically feasible liver tumour cell size measurement through histology-informed diffusion MRI

Francesco Grussu,Kinga Bernatowicz,Marco Palombo,Irene Casanova-Salas,Daniel Navarro-Garcia,Ignasi Barba,Sara Simonetti,Garazi Serna,Athanasios Grigoriou,Carlos Macarro,Anna Voronova,Valezka Garay,Juan Francisco Corral,Marta Vidorreta,Pablo García-Polo García,Xavier Merino,Richard Mast,Núria Rosón,Manuel Escobar,Maria Vieito,Rodrigo Toledo,Paolo Nuciforo,Joaquin Mateo,Elena Garralda,Raquel Perez-Lopez
DOI: https://doi.org/10.1101/2024.04.26.24306429
2024-12-01
Abstract:Innovative diffusion Magnetic Resonance Imaging (dMRI) models enable the non-invasive measurement of cancer biological properties . However, while cancers frequently spread to the liver, models tailored for liver application and easy to deploy in the clinic are still sought. We fill this gap by delivering a practical, clinically-viable dMRI framework for liver tumour imaging, informing its design through histology. By comparing dMRI and histological data from mice and cancer patients, we select a dMRI signal model of restricted intra-cellular diffusion with negligible extra-cellular contributions, maximising radiological-histological correlations. The model enables non-invasive liver cancer phenotyping, providing cell size and density estimates that i) correlate with their histopathology counterparts, ii) are associated to cell proliferation and tumour volume, and iii) that distinguish tumour types. By delivering metrics that are biologically meaningful, our approach may complement standard-of-care radiology, and become a new tool for enhanced cancer characterisation in precision oncology.
Radiology and Imaging
What problem does this paper attempt to address?